LEVILIMAB
UNII P7UV3L2H80

Substance Identification & Data

This profile provides standardized clinical and technical data for Levilimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) P7UV3L2H80.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2035008-70-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

P7UV3L2H80

CAS Registry Number

2035008-70-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LEVILIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C173804

National Cancer Institute reference terminology for clinical and research data.

INN ID

10905

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Levilimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LEVILIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 6 RECEPTOR) (HUMAN MONOCLONAL BCD-089 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL BCD-089 .KAPPA.-CHAIN, DIMER

LEVILIMAB [INN]

LEVILIMAB [WHO-DD]